Implementation of the Haemophilus B vaccine for infants by family physicians.
This study surveyed the members of the Department of Family Practice in a community hospital regarding the implementation of the newly recommended immunization protocol using Haemophilus Influenzae B Vaccine (HbOC) for infants at 2, 4, and 6 months of age. The purpose was to assess the ability of the physicians to alter their established practices in a timely fashion. The results show that initially 38/66 (58 percent) of the family physicians who care for infants and children were using the new vaccine already (eight to 10 weeks after FDA release). An additional 11 (17 percent) had begun using the vaccine by a second interview four weeks later. Another six (nine percent) responded to a call by a family practice resident. The remaining 16 percent preferred to await governmental regulations or did not respond to interview. Despite uncertain communications to family physicians in this community, the majority were aware of and adapted readily to new immunization recommendations. Prompt notification of all physicians regarding important new vaccine protocols can have a significant impact on the health of infants and children.
Funk
W B
WB
Department of Family Medicine, St. Francis Hospital, Wilmington, Delaware.
Urban
B P
BP
D001291:Attitude of Health Personnel; D001426:Bacterial Proteins / Q000008:administration & dosage*; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D003691:Delaware; D005194:Family Practice; D006192:Haemophilus Infections / Q000276:immunology / Q000517:prevention & control*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology*; D006801:Humans; D007223:Infant
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C061963:HibTITER protein, Haemophilus influenzae